IDH2 and acute myeloid leukemia: Namely, historic samples from those who went on to develop AML show that these patients have greater numbers of mutations, higher variant allele frequencies, and distinct patterns of mutations in specific genes, including TP53, IDH1, and IDH2 [28,29].